Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Lactase Expression by a New Synthetic PPARgamma Ligand in Ex-vivo Cultures of Duodenal Biopsies

NCT02902016 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02902016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02902016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Lactase Expression by a New Synthetic PPARgamma Ligand in Ex-vivo Cultures of Duodenal Biopsies
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2015
Completion date
September 30, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lactose intolerance